- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 597253, 7 pages
The Adjunctive Digital Breast Tomosynthesis in Diagnosis of Breast Cancer
1Department of Radiology, Kaohsiung Veterans General Hospital, Kaohsiung 81362, Taiwan
2National Yang-Ming University, Taipei, Taiwan
Received 8 January 2013; Revised 19 April 2013; Accepted 9 May 2013
Academic Editor: Mei-Hsiu Liao
Copyright © 2013 Tsung-Lung Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Purpose. To compare the diagnostic performance of digital breast tomosynthesis (DBT) and digital mammography (DM) for breast cancers. Materials and Methods. Fifty-seven female patients with pathologically proved breast cancer were enrolled. Three readers gave a subjective assessment superiority of the index lesions (mass, focal asymmetry, architectural distortion, or calcifications) and a forced BIRADS score, based on DM reading alone and with additional DBT information. The relevance between BIRADS category and index lesions of breast cancer was compared by chi-square test. Result. A total of 59 breast cancers were reviewed, including 17 (28.8%) mass lesions, 12 (20.3%) focal asymmetry/density, 6 (10.2%) architecture distortion, 23 (39.0%) calcifications, and 1 (1.7%) intracystic tumor. Combo DBT was perceived to be more informative in 58.8% mass lesions, 83.3% density, 94.4% architecture distortion, and only 11.6% calcifications. As to the forced BIRADS score, 84.4% BIRADS 0 on DM was upgraded to BIRADS 4 or 5 on DBT, whereas only 27.3% BIRADS 4A on DM was upgraded on DBT, as BIRADS 4A lesions were mostly calcifications. A significant value (<0.001) between the BIRADS category and index lesions was noted. Conclusion. Adjunctive DBT gives exquisite information for mass lesion, focal asymmetry, and/or architecture distortion to improve the diagnostic performance in mammography.
Breast cancer remains one of the leading causes of death in women over the age of 40 years [1, 2]. Mammography is an effective imaging tool for the detection of early-stage breast cancer, and it is the only screening modality proved to reduce mortality from breast cancer [3–5]. The sensitivity of screening mammography for breast cancer had been reported to be 80%–90% but may be as low as 48% in extremely dense breast  because of overlapping dense fibroglandular breast tissue, which substantially reduces the conspicuity of some breast lesions. Digital breast tomosynthesis (DBT) is expected to overcome the inherent limitations of mammography caused by overlapping of normal and pathological tissues during the standard two-dimensional (2D) projections [7–10]. In a DBT system, the X-ray tube moves along an arc during the examination, and a finite number of 2D projections are acquired within a limited angle. The 3D volume of the compressed breast is reconstructed from the 2D projections, allowing enhancement of the information contained in each plane while blurring the off-focus information. Thus, DBT can provide better tissue visualization through the provision of 3D nonoverlapped tissue information. Several studies have shown that tomosynthesis may offer superior diagnostic accuracy, not only in the routine diagnostic practice [9, 11–14], but also in breast cancer screening , in the evaluation of breast lesions. Poplack et al.  concluded that subjectively, DBT has comparable or superior image quality versus full-field digital mammography (DM) and has the potential to reduce screening recall rates when used in adjunction with DM. Andersson et al.  concluded that cancer visibility on DBT in one view is superior to full-field DM in two views and that this would indicate the potential of DBT to increase sensitivity.
In this study, we compared the diagnostic performance of 59 pathologically proved breast malignancy in a multireader retrospective study to determine whether or not simultaneously viewing DM and DBT is perceived to be more informative in detection (including assessing the features of masses, asymmetries, architectural distortions, and microcalcifications) and diagnosis (BIRADS score) of breast cancers.
2. Materials and Methods
Inclusion criteria for this study were patients who had pathologically proved breast cancer and had undergone both DM and DBT during the period of January 2012 to November 2012. This retrospective review of research database was conducted with the approval of the institutional review board. The demographic data, including age, clinical symptom and sign, mammographic findings, and histopathologic staging, was recorded as a case report form in a secure research database. The mammographic findings included the density of breast, the type of malignant features (mass, architectural distortion, focal asymmetric density, and calcification), and breast imaging reporting and data system (BIRADS) score. If the findings were mixed, we recorded the most conspicuous findings. In cases where there was more than one lesion, a separate form was created for each lesion.
2.2. Image Acquisition
Selenia Dimensions (Hologic Inc., Bedford, MA) “combo-mode” imaging system with mediolateral oblique and craniocaudal projections was applied in this study with acquiring a traditional digital mammogram and a tomosynthesis scan during the same breast compression. It employs a tungsten (W) target and a selenium (Se) detector with a rhodium (Rh) filter, a silver (Ag) filter for 2D images, an aluminum (Al) filtration in tomosynthesis images. During acquisition, 15 low-dose projection images with exposure parameters of 29 kVp and 44 mAs are obtained over a 15° arc with a continuous exposure method. After acquisition, raw data of the projection images are used for reconstruction to yield images of 1 mm thickness in an orientation paralleling to the detector with totaling 30–80 tomosynthetic images per view depending on the breast thickness being compressed. The reconstructed pixel size is 110–120 μm. The total acquisition time for one breast tomosynthesis view is approximately 3 seconds. Radiation dose to single breast view is about 1.45 mGy.
The radiologists viewed individually or sequentially a dynamic cine mode at a mammography workstation (Hologic Inc., SecurView) that included two Barco 5-megapixel monitors (Kortrijk, Belgium), allowing the viewing of one, two, or four images per display for each monitor.
2.3. Image Assessment
The selection of cases was performed by one radiologist who did not participate in the subjective rating study and knew from the relevant reports the actual diagnosis of all cases, in particular, the index lesion of interest. The index lesion of interest location was recorded for each case by this radiologist on a data form so that readers knew which lesion to evaluate. Three board-certified radiologists with varying breast imaging experience ranging from 5 to 15 years volunteered for the study. Readers were told to assume the screening DM examination was the woman’s baseline examination; hence, no prior DM examinations were provided for comparison. Readers were asked to provide a subjective assessment of how well the combination of DM and DBT examinations is compared with DM alone for the purpose of evaluating the index lesion. A scale of 0 to 2 was provided and used with 0 indicating that DM plus DBT was equivalent or comparable for diagnosis compared with DM, 1 indicating that DM plus DBT was somewhat better for diagnosis, 2 indicating that DM plus DBT was definitely better for diagnosis compared with DM alone. After the interpretation, readers were asked to provide a forced BI-RADS score (1–5) for each index lesion, based on DM reading alone and with additional DBT information.
Based on ACR recommendation , type (1–4) of breast density indicates tissue density almost entirely fat, scattered fibroglandular density, heterogeneously dense, and extremely dense, respectively. Focal asymmetric breast density is defined as “asymmetry of tissue density with similar shape on two views but completely lacking borders and the conspicuity of a true mass.”
Architectural distortion is defined as the normal architecture of the breast that is distorted with no definite mass visible. This includes spiculations radiating from a point and focal retraction or distortion at the edge of the parenchyma. Architectural distortion can also be an associated finding. As to the calcifications, amorphous or coarse heterogeneous calcifications are of intermediate concern and fine pleomorphic or fine linear or fine linear branching calcifications are of higher probability of malignancy. Cluster, linear, or segmental distribution of microcalcifications is suspicious for malignancy. Cluster, linear, or segmental distribution of microcalcifications is suspicious for malignancy.
2.5. Data Analysis
We calculate the mean of 57 patient’s age. Then, we computed the frequency and proportion of the patient characteristics, the subjective ratings, and the BIRADS ratings of overall readers and cancer cases. For the purpose of this analysis, subjective ratings 1 and 2 were combined. Chi-square test was used to compare the relevance between BIRADS category and index lesions of breast cancer.
Fifty-seven patients (mean age 53.5 years, range 26–89 years) with pathologically proved breast cancers who had undergone combo DBT for either screening or diagnostic purposes were enrolled in this retrospective study. Two patients had a second malignancy in the ipsilateral breast. Thus, a total of 59 breast cancers were reviewed in this study. Thirty patients (52.6%) were symptomatic with positive breast physical examination during mammography taken. The location of the breast cancers were 31 lesions on the right and 28 on the left. As to the breast composition (BI-RADS type), most (up to 79%) patients in our series had dense breast (type 3 or 4) with type 1 in two (3.5%) patients, type 2 in 10 (17.5%), type 3 in 27 (47.3%), and type 4 in 18 (31.6%). Of the 59 index lesions, 17 (28.8%) lesions were presented as mass (Figure 1), 12 (20.3%) as focal asymmetry/density (Figure 2), 6 (10.2%) as architecture distortion (Figure 3), and 23 (39.0%) as calcifications (Figure 4). One intracystic tumor (1.7%), which was clinically palpable and diagnosed by US images, failed to show malignant feature on either DM or tomosynthesis images (Figure 5) and therefore was considered as truly false negative. BIRADS category of the fifty-seven patients was initially rated as 0 in 20 cases (35%), 4A in 8 (14%), 4B in 9 (15.8%), 4C in 7 (12%), and category 5 in 13 cases (22.8%), respectively, with final clinical staging of ductal carcinoma in situ (DCIS) in 16 cases (28.1%), stage 1 in 17 cases (29.8%), and T1N1 or above in 24 cases (42.1%). The demographic and clinical results of these 57 patients were listed in Table 1.
For the overall 59 target lesions interpreted by 3 readers, combo DBT was perceived to be more informative for diagnosis in 48% (85/177) of the subjective ratings (59 lesions × 3 readers = 177 ratings). A superior rating of the index lesions was considered in 30 of 51 (58.8%) mass lesions, 30 of 36 (83.3%) density lesions, 17 of 18 (94.4%) architecture distortion lesions, while only 8 of 69 (11.6%) in calcification lesions. The 85 superior ratings of 1 or 2 occurred in 34 patients in which at least one radiologist had given a positive rating. Of whom, 73.5% were dense breasts (type 3 or 4) with type 1 breast in 2 (5.9%) patients, type 2 breast in 7 (20.6%) patients, type 3 breast in 16 (47%) patients, and type 4 breast in 9 (26.5%) patients. The ratings of overall and each relevant index lesion were listed in Table 2.
As to the retrospective review of BI-RADS score in the 57 cancer patients (171 ratings), BI-RADS 0 and 4A were rated 64 (37.4%) and 33 (19.3%) on DM versus 10 (5.8%) and 29 (16.9%) on combo tomosynthesis, respectively. Of the 64 BIRADS 0 rated on DM, 10 (15.6%) ratings were still categorized as BIRADS 0 on combo tomosynthesis, while upgraded to 4A in 4 (6.3%), 4B in 22 (34.4%), 4C in 17 (26.6%), and category 5 in 11 (17.2%), whereas, in the 33 BIRADS 4A ratings on DM, 24 (72.7%) were still categorized the same, while being upgraded to 4B in 5 (15.2%) and 4C in 4 (12.1%), respectively, with additional reviewing of the 3D tomosynthesis images. Of the BIRADS 4A patient group, calcification was the dominant lesion in 31 (93.9%) of the 33 ratings. The overall forced BI-RADS scores on digital mammograms and tomosynthesis were listed in Table 3. Although there seemed to be of little improvement of the DBT diagnosis on calcification lesions, markedly improved diagnostic performance of density, distortion, and mass lesions was noted in this study. The forced BIRADS score of 0, 4, and 5 versus each type of lesion was listed in Table 4. Comparing the BIRADS category (category 0 versus 4A versus 4B + 4C + 5) and index lesions by the use of chi-square test, a significant value(<0.001) was noted (Table 5).
The malignant features of breast cancers can be classified as mass, focal asymmetry, architecture distortion, and microcalcification. Better delineations of the lesion border and margin result in a more definitive interpretation. Previous studies concluded that the shape and margin of the mass in tomosynthesis were well characterized than DM [9, 13]. Thus, small undulating contour or subtle speculated margins of masses can be identified on a thin slide without normal breast tissue masking. Our study confirmed that 58.8% of mass index lesions had superior rating on tomosynthesis versus DM alone.
Focal asymmetric breast density is found in approximately 3% of mammograms . A review of the literature showed that malignancy can be found in 0%–14% of asymmetric breast tissue biopsies, and any associated features of possible malignancy, or a clinically palpable mass mandates tissue diagnosis . However, the lesion presented as focal asymmetric breast density on 2D mammograms may lack its conspicuous borders, making the diagnosis of malignancy difficult in a sole “asymmetry” finding. Although, the focal density on DBT is presented as an ill-defined mass but it still definitely has a border and volume size. Thereafter, it can be easily distinguished from an island of normal breast tissue. In other words, a lesion with 5 mm in size would be detected in at least five 1 mm contiguous slices even if it presented as a focal asymmetry. In our study, 83.3% density reading were rated as superior to that of DM only with 85.2% (23/27) BIRADS 0 being upgraded to BIRADS 4 or 5.
On mammograms, the breast is seen as a directionally oriented-textured image due to the presence of several piecewise linear structures such as ligaments, ducts, and blood vessels. The presence of tumor, inflammation, trauma, or surgery may change the orientation of normal architecture, whereas the presence of overlapping dense fibroglandular breast tissue may substantially reduce the conspicuity of the changes. It was reported that architectural distortion accounted for 12% to 45% of overlooked or misinterpreted breast cancer cases in screening mammographies [20, 21], and it constituted the most commonly missed abnormality in false-negative cases. As the barrier of false negative for distortion lesions is chiefly related to overlapped tissue, DBT was proved to be an expectant method to solve this problem . In our study, 94.4% distortion reading were rated as superior to that of DM only with all the BIRADS 0 being upgraded to BIRADS 4 or 5.
Our study also showed markedly improved diagnostic accuracy for noncalcified lesions on tomosynthesis mammograms with 78.2% initially scored as BIRADS 0 on DM being upgraded to equal or higher than RIRADS 4B, which may allow for the replacement of conventional supplemental mammographic views. Our series showed only mild-modest improvement of the diagnostic accuracy in the patient group initially scored as BIRADS 4A with 72.7% of patients remaining with the same score. It was because most of the lesions (93.9%) in this patient group were microcalcifications. The clinical benefits of tomosynthesis on calcified lesions may be still debated with the concern of not depicting calcifications as well as traditional mammography . However, increasing the slice thickness would increase the ability to perceive a 3D configuration of calcifications, and the extents of accompanying microcalcifications may be better depicted on BDT than on 2D mammograms . Thereafter, Spangler et al.  concluded that DM appeared to be slightly more sensitive than DBT for the detection of calcification (84% versus 75%). However, diagnostic performance as measured by area under the curve using BIRADS was not significantly different. Other studies had also supported the diagnostic performance of digital breast tomosynthesis in conjunction with  or independently [24, 25] of full-field DM.
A major limitation of this study was that it involved a nonblinded retrospective review of only pathologically proved breast cancer images. The true diagnostic accuracy of combo DBT in general population is unclear. But with more familiarity with the imaging features of breast malignancy on DBT, it may help us interpret the tomosynthesis more precisely. In addition, the term of focal asymmetry is defined in 2D side by side interpretation, but for ease to compare with previous tomosynthesis studies, we still use the term of focal asymmetry instead of focal density.
In conclusion, adjunctive DBT gives exquisite information for mass lesion, focal asymmetry, and/or architecture distortion to improve the diagnosis in mammography with comparable performance to the pattern of microcalcifications on 2D mammogram, yet the additional associating findings such as intraductal calcification may give some clues to confirm malignancy.
Conflict of Interests
The authors have no potential conflict of interests to disclose.
- C. Mettlin, “Global breast cancer mortality statistics,” Ca-A Cancer Journal for Clinicians, vol. 49, no. 3, pp. 138–144, 1999.
- R. A. Smith, “Breast cancer screening among women younger than age 50: a current assessment of the issues,” Ca-A Cancer Journal for Clinicians, vol. 50, no. 5, pp. 312–336, 2000.
- L. Nystrom, L. E. Rutqvist, S. Wall et al., “Breast cancer screening with mammography: overview of Swedish randomised trials,” The Lancet, vol. 341, no. 8851, pp. 973–978, 1993, Published correction appears in The Lancet, vol. 342, p.1372, 1993.
- L. Tabar, C. J. Fagerberg, A. Gad, et al., “Reduction in mortality from breast cancer after mass screening with mammography: randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare,” The Lancet, vol. 1, no. 8433, pp. 829–832, 1985.
- J. M. Lewin, C. J. D'Orsi, and R. E. Hendrick, “Digital mammography,” Radiologic Clinics of North America, vol. 42, no. 5, pp. 871–884, 2004.
- T. M. Kolb, J. Lichy, and J. H. Newhouse, “Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations,” Radiology, vol. 225, no. 1, pp. 165–175, 2002.
- L. T. Niklason, B. T. Christian, L. E. Niklason et al., “Digital tomosynthesis in breast imaging,” Radiology, vol. 205, no. 2, pp. 399–406, 1997.
- J. T. Dobbins III and D. J. Godfrey, “Digital x-ray tomosynthesis: current state of the art and clinical potential,” Physics in Medicine and Biology, vol. 48, no. 19, pp. R65–R106, 2003.
- M. P. Jeong, E. A. Franken Jr., M. Garg, L. L. Fajardo, and L. T. Niklason, “Breast tomosynthesis: Present considerations and future applications,” Radiographics, vol. 27, supplement 1, pp. S231–S240, 2007.
- E. A. Rafferty, “Digital Mammography: novel Applications,” Radiologic Clinics of North America, vol. 45, no. 5, pp. 831–843, 2007.
- G. Gennaro, A. Toledano, C. Di Maggio et al., “Digital breast tomosynthesis versus digital mammography: a clinical performance study,” European Radiology, vol. 20, no. 7, pp. 1545–1553, 2010.
- I. Andersson, D. M. Ikeda, S. Zackrisson et al., “Breast tomosynthesis and digital mammography: a comparison of breast cancer visibility and BIRADS classification in a population of cancers with subtle mammographic findings,” European Radiology, vol. 18, no. 12, pp. 2817–2825, 2008.
- M. L. Zuley, A. I. Bandos, M. A. Ganott, et al., “Digital breast tomosynthesis versus supplemental diagnostic mammographic views for evaluation of noncalcified breast lesions,” Radiology, vol. 266, pp. 89–95, 2013.
- P. Skaane, R. Gullien, H. Bjørndal, et al., “Digital breast tomosynthesis (DBT): initial experience in a clinical setting,” Radiologica, vol. 53, pp. 524–529, 2012.
- A. Tejerina Bernal, A. Tejerina Bernal, and F. Rabadn Doreste, “Breast imaging: how we manage diagnostic technology at a multidisciplinary breast center,” Journal of Oncology, vol. 2012, Article ID 213421, 9 pages, 2012.
- S. P. Poplack, T. D. Tosteson, C. A. Kogel, and H. M. Nagy, “Digital breast tomosynthesis: Initial experience in 98 women with abnormal digital screening mammography,” American Journal of Roentgenology, vol. 189, no. 3, pp. 616–623, 2007.
- American College of Radiology (ACR), Illustrated Breast Imaging Reporting and Data System (BI-RADS), American College of Radiology, Reston, Va, USA, 4th edition, 2003.
- C. W. Piccoli, S. A. Feig, and J. P. Palazzo, “Developing asymmetric breast tissue,” Radiology, vol. 211, no. 1, pp. 111–117, 1999.
- F. Sperber, U. Metser, A. Gat, A. Shalmon, and N. Yaal-Hahoshen, “Focal asymmetric breast density: mammographic, sonographic and pathological correlation in 97 lesions—a call to restrain biopsies,” Israel Medical Association Journal, vol. 9, no. 10, pp. 720–723, 2007.
- B. C. Yankaskas, M. J. Schell, R. E. Bird, and D. A. Desrochers, “Reassessment of breast cancers missed during routine screening mammography: a community-based study,” American Journal of Roentgenology, vol. 177, no. 3, pp. 535–541, 2001.
- H. C. Burrell, A. J. Evans, A. Robin, M. Wilson, and S. E. Pinder, “False-negative breast screening assessment. What lessons can we learn?” Clinical Radiology, vol. 56, no. 5, pp. 385–388, 2001.
- M. L. Spangler, M. L. Zuley, J. H. Sumkin et al., “Detection and classification of calcifications on digital breast tomosynthesis and 2D digital mammography: a comparison,” American Journal of Roentgenology, vol. 196, no. 2, pp. 320–324, 2011.
- D. Gur, G. S. Abrams, D. M. Chough et al., “Digital breast tomosynthesis: observer performance study,” American Journal of Roentgenology, vol. 193, no. 2, pp. 586–591, 2009.
- D. Kontos, P. R. Bakic, A.-K. Carton, A. B. Troxel, E. F. Conant, and A. D. A. Maidment, “Parenchymal texture analysis in digital breast tomosynthesis for breast cancer risk estimation: a preliminary study,” Academic Radiology, vol. 16, no. 3, pp. 283–298, 2009.
- H. J. Teertstra, C. E. Loo, M. A. A. J. Van Den Bosch et al., “Breast tomosynthesis in clinical practice: initial results,” European Radiology, vol. 20, no. 1, pp. 16–24, 2010.